Why We’re Bringing A Hackathon To Barking And Dagenham

Here’s a fun game: what is it that links Facebook’s ‘Like’ button, the most downloaded taxi app in the world and the London Borough of Barking and Dagenham?
 
The answer, you may be surprised to learn, is hackathons.
 
For the uninitiated, a hackathon is when a group of people come together to identify problems and find solutions to them using the wonders of technology, typically over a couple of days. When Facebook wanted to improve people’s engagement with each other, they held a hackathon and ended up creating their famous ‘thumbs up’. When one man had to wait an hour and half in the rain for a cab in Rio de Janeiro, he and his colleagues came together to try and solve the inefficiencies of local public transport. Easy Taxi was born.
 
So, what does all this mean for Barking and Dagenham?
 
Our borough typifies London: its celebrated past, its vibrant present, its relentless optimism about the future. It was once the home of England’s 1966 World Cup-winning manager Sir Alf Ramsey and its captain Bobby Moore. It was the scene of the Sewing Machine Strikes, immortalised in the hit film ‘Made in Dagenham’ for their part in the battle for equal pay in the workplace. During the 2012 Olympics, arguably London’s finest moment of recent decades, we were a host borough.
 
This is an area with an exciting future. Huge regeneration is planned, including new transport links and housing. People want to be here, and when they come, they want to stay: we were recently crowned England’s property renovation hotspot. Like so much of London, Barking and Dagenham has changed and continues to change at a rapid pace. The borough is more diverse than it has ever been and we celebrated that recently through our Summer of Festivals. But while this is all testament to the success of our area, it also poses challenges. The question for us all is how do we ensure that everyone in Barking and Dagenham – no matter what background or faith you come from – has a stake and a say in our community.
 
It’s that question that has led to Barking and Dagenham teaming up this weekend with local technology company DigiLab to host the UK’s first ever social-cohesion hackathon. By bringing together tech experts and service designers with local people of all ages and backgrounds, we will respond to and tackle the issues and concerns of residents. 
 
By the end of the weekend we will start to develop practical ways to improve the way services work for our communities, find solutions to challenge perceptions of public safety, bring different generations of people together across the borough, or help to encourage the reporting of hate crime. The only limits to what we can achieve are our imaginations, and what matters most is that it is local people who will decide.
 
In modern Britain, with the technology and the talent available to us, this should be the norm, not a one-off: bringing people together and empowering them to build the society they want to see.
 
This is an exciting opportunity for us. If you’re in the local area, sign up and come along. If you’re a service designer or tech expert wanting to create meaningful solutions to everyday problems get in touch. If you’re not, we will be updating on our progress during and after the weekend, so take a look at our social media pages to find out more. Oh, and while you are there, don’t forget to hit the ‘Like’ button.
 
Councillor Darren Rodwell is leader of Barking and Dagenham Council

Share Button

Apple And Fitbit Show That Smartwatches Are Still Very Much Alive And Kicking

2017-09-28-1506612965-7841451-25746882890c075cffb95eccf39ac4185c7d6.jpg

Credit: Wareable

For the past few weeks I’ve been wearing the new Apple Watch Series 3 on my left wrist and the Fitbit Ionic, the company’s first ever smartwatch, on my right.

The experience of using both at the same time has been interesting to say the least. On the one hand (well, wrist), there’s Apple’s third generation Watch, which has come on leaps and bounds since the first one and is finally starting to provide a more compelling argument that iPhone owners need one in their lives.

Notifications have been a smartphone staple for what seems like forever and above anything else, this is what I’ve found myself tapping into most on the Watch Series 3. A glance at my wrist on a packed tube carriage or running on a treadmill in the gym. I don’t tend to deal or respond to these notifications a lot of the time, but it’s nice just to be aware of what’s happening at work or knowing there’s a WhatsApp group conversation I need to be part of. I know, a smartphone does this already, but normally when I grab my phone it means spending time checking in on Twitter, Instagram and a bunch of other apps. Basically, more screen time.

Apple’s third smartwatch does a pretty credible impression of a sports watch too. It’ll track my swims and runs and not leaving me waiting achingly long for a GPS signal to lock on. There’s also something quite addictive about closing those Activity rings before my other Apple Watch owning friends. Until battery life gets significantly better though, I’m not sure it’ll ever replace a dedicated sports watch, but for most, it does tick the boxes.

2017-09-28-1506613845-1233872-Apple_Watch_Series_3_inline.jpg

The big new addition of course is LTE, which has been available on smartwatches before, but means I can leave my iPhone behind and get a smartphone-like experience on my watch. Taking and making calls from my wrist or asking Siri about appointments in my calendar in public is just something I’m never going to get used to. But the notification support or the ability to stream music (which isn’t available just yet) without having to remember to transfer new music over to the watch iTunes could persuade me to spend a little more for the luxury. Ultimately, though I still want my smartphone by my side. What happens when you want to grab a quick snap of something? A smartwatch just isn’t cut out for that.

Then there’s the Ionic, the only other smartwatch that has been talked about as much as Apple’s. Fitbit has taken its fitness tracker DNA and put it inside of a design that is best described as Marmite. Some will love it, some will hate it. Unsurprisingly, fitness tracking is where the Ionic impresses most, but it does a decent job as a smartwatch too. Notification support is more basic than Apple’s approach, but features like Fitbit Pay contactless payments work effortlessly and while there aren’t too many standalone apps right now, the few that are there, work well.

2017-09-28-1506613898-2151312-Fitbit_Ionic_5440.jpg

Fitbit’s CEO James Park gave his reasons why the company didn’t include LTE in its first smartwatch, and I’m inclined to agree with what he had to say on the feature for now. But there’s a sense of inevitability that it will be on the Fitbit agenda further down the line. One of those reasons will no doubt have been battery life, one of the biggest differentiators between Apple and Fitbit’s smartwatches and the reason the Ionic spends more time on my wrist. It just lasts longer (four days to Apple’s day and a half) even with a super bright display and that’s something Apple is going to have to seek to improve. Because if it does, then Fitbit will seriously have to raise its game.

The real litmus test for any piece of technology is whether it has the ability to stick around and when I mean stick around, I mean you are still using it for more than a few weeks after you first pull it out of the box. In the case of the Watch Series 3 and the Ionic, they will be sticking around. At least they will be for me. I’ve not really been able to say that about a lot of smartwatches before, but both Apple and Fitbit have gone some way to prove that smartwatches do have a future at a time when many still doubt it. Couple that with Google’s more fashion focused approach to Android Wear through partnerships with the Fossil Group and Movado, or Garmin’s ability to blend proper sports tracking with watch smarts, and it finally feels like smartwatches are going in the right direction.

Now there are strong options to choose from, options that offer different answers to what a smartwatch should be and what they should do. It finally feels like the benefits of owning one are starting to be realised and if the news that Apple is now the number one watchmaker in the world tells us anything, it’s that it’s time to accept that smartwatches aren’t going anywhere.

Share Button

Does AI Make You WannaCry?

Cyber-security threats. Ransomware attacks. Software malfunctions. These terms used to be reserved for the most advanced sci-fi films and IT professionals. In a case of life imitating art, these terms have now entered the everyday lexicon and have a real-world impact, outside of the IT department. The recent WannaCry ransomware attack crippled the UK’s NHS’ IT systems, causing appointments to be cancelled and operations to be postponed. Similarly, we saw British Airways fall foul to a software outage which grounded every commercial flight from Gatwick and Heathrow for 24 hours, obviously ruining or, at least delaying, thousands of passenger’s holiday and travel plans. We are used to seeing doomsday cyber scenarios play out in movies, but as our lives become ever more affected by those who wish to cause cyber chaos, can we truly trust technology in this day and age?

The invisible threat

Technology is truly integrated into every aspect of our life. We use technology to work, to relax, for entertainment, to communicate, to plan our schedule, and now some can even use it to do laundry. It stands to reason that the more we rely on technology, the more we need to trust that it will just simply work. But cyber security threats and software issues have the potential to negatively impact the way we live and, in many cases, has made us sceptical when it comes to adopting new technologies. Why would we trust gadgets and services such as AI and self-driving cars that we have seen cause hypothetical worldwide chaos time and time again on the big screen, when simple software faults can ground planes and destroy our health service in real life? Our recent study looked into our perception of emerging technology and it makes for grim reading if you are a technology company. Almost 80 per cent of UK adults looking to buy AI products in the future may reconsider due to the threat of hackers targeting technology. And nearly half (48 per cent) of us claim that we would not purchase AI devices at all due to the threat of cyber-attacks. The revelations regarding 1984-esque Orwellian hacking tools developed and used by the CIA and British intelligence to spy on household connected devices is just one reason why we as consumers are concerned about emerging technology.

The reality of the situation is that society is not yet comfortable with embracing the technology we have watched destroy or take over the world in films time after time. But it is now becoming increasingly obvious that our negative perception is standing in the way of the potential for positive digital transformation and is an issue technology companies must address, if we are to embrace emerging technology.

Who is the master?

Home robots have been designed to help us and eliminate household chores, who would be against that? The problem is that we have seen these devices regularly depicted negatively on-screen. For instance, the AI robotic creation, Ultron, featured in Marvel’s latest Avengers superhero flick was designed with the intention of helping humanity, but inevitably acts in a destructive way that was not intended. In this world, Thor, Iron Man and Captain America were on hand to neutralise the cold hearted robotic threat, but outside the Marvel cinematic universe, the real world does not have a super-powered villain deterrent. Indeed, our study also revealed that less than a quarter (24 per cent) of us believe home robots are safe with over half (52 per cent) concerned they could also fall victim to cyber criminals with malicious intentions. It is, therefore, more important than ever for companies producing home robots to prove these devices are not a menace to society, but are designed to help make our lives easier.

But there is hope! Companies such as Tesla, Apple and Microsoft are pouring a huge amount of time, energy and talent in to developing innovative AI technology, all of which proves that companies are taking our concerns seriously.

It is up to manufacturers of such technology to prove to us that doomsday predictions made in films are works of fiction and nothing more. It is crucial that they place a high importance on prioritising quality to protect the population thus gaining our confidence in regards to emerging technologies. Quality must be integral and prioritised from the initial concept of a new tech product right through to when the device hits the shelf.

Ultimately, if innovations such as AI, autonomous vehicles and smart homes are to become part of our everyday life, government and businesses have a duty to prove to every one of us that stringent precautions have been taken to safeguard and protect human life. Quality is non-negotiable and by proving this is at the core of innovation, businesses will begin to change our current perception of advanced technology.

Share Button

Elon Musk’s SpaceX Rocket Could Fly You Anywhere On Earth In Under An Hour

Elon Musk might be determined to travel to Mars, but that doesn’t mean he isn’t thinking about closer to home.

The SpaceX founder has revealed that the Interplanetary Transport System spacecraft could actually be used to travel around Earth and could in theory, take you anywhere on the planet in under an hour.

SpaceX

Speaking at the International Astronautical Congress (IAC), Musk explained that the ITS would be attached to SpaceX’s new BFR (which stands for exactly what you think it does) and could propel passengers to most of the world in under 30 minutes and the rest of the globe in under an hour.

If you’re thinking that this is just a new and exciting way for the super rich to get from A to B you’re going to be sorely mistaken.

Musk claims that the cost would be around the same as a full-fare economy ticket.

As you can see from the promotional video above, the BFR detaches after doing the heavy lifting and lands itself back on the launchpad. The ITS then carries on with its journey and lands just 39 minutes later.

Musk’s vision of course extends beyond Earth, and the Interplanetary Transport System will be the flagship that he believes can take humans to Mars.

Share Button

Augmenting Our Mental Health

This week I had the privilege of joining some of the country’s foremost mental health practitioners at Mayden’s Improving Access to Psychological Therapies (IAPT Connect 2017) conference to hear about the latest trends and practice in this increasingly high profile area. There were the leading lights in commissioning, delivery and policy, from both the adult and children and young people (CYP) spheres of mental health.

As a layman, it was both enlightening and humbling to meet the people at the sharp end of what many describe as a ‘Cinderella Service.’ There were of course harrowing stories from the perspective of mental health service users and those who treat them.

But what really struck me was how forward looking the delegates were in terms of technology. Doing a fair amount of work in the field of Artificial Intelligence currently, I must admit I was not expecting AI and augmented reality to be on the agenda of those working with mental health patients. But what do I know, apparently!

This part of our nation’s health service isn’t bogged down in the common debates on pay, staffing, budgets, and reform (though they had all of course read Simon Stevens’ Five Year Forward View). They were instead passionately focused on wielding the technology at our disposal to manage people’s conditions in new ways.

Chaise longue are old hat in psychology now, Minecraft and Pokémon Go are in. I’m not being facetious, gaming is now a genuine, credible avenue for exploring new approaches to mental health. We were shown a fascinating example of a Cognitive Behaviour Therapy (CBT) programme that gives the user an avatar to interact with issues in a fantasy world which allows them to overcome their personal challenges in a safe space. But this wasn’t about replacing human interaction with gadgets and games, nor was it about working with more patients using less people. It was about using tools to augment/complement the work of more conventional face-to-face therapy.

We heard of a case of an individual with acute autism who could not cross bridges, but practicing on a Virtual Reality version allowed them to overcome their fear. Crossing a bridge may sound trivial to you and I, but to this individual it was life changing. Another touching case was of children who would struggle to leave their houses due to crippling anxiety, who then found a new lease for the outdoors at the prospect of rounding up a 100+ Pokémon.

What became an increasingly clear part of the picture was that these strides had come partly due to the new generation of professionals entering the sector. Not only were they new, enthusiastic and un-jaded, many were of a millennial generation who have grown up with computing, apps, ‘tech’, as part of their daily lives. It is perhaps therefore no surprise that they are exploring ways to use that tech to do their jobs differently and better.

It seems that our other public services may have a lot to learn from Cinderella.

Share Button

Health24.com | Is it OK to use older blood for transfusions?

In April 2017 it was reported that the South African National Blood Service (SANBS) was facing a serious shortage of type O blood, with just over a day and a half’s supply in its banks across the country.

The current blood stock at SANBS is enough for 2.2 days, the major shortage still being type O blood.

It was once believed that fresh red blood cells were best suited for transfusions. But a new Australian study has added to the evidence that older blood is just as good, if not better.

Using older red blood cells in transfusions to critically ill patients doesn’t appear to increase their risk of dying, Australian researchers report.

A little older, a little better

“Red blood cells for transfusion for critically ill patients are like a good red wine – a little older, a little better,” said researcher Dr Jamie Cooper. He is professor and director of the Australian and New Zealand Intensive Care Research Centre at Monash University in Melbourne.

Study co-author Alistair Nichol added that a lot of inadequate research had suggested that fresher blood would be better to use in critically ill patients. Nichol is an associate professor of epidemiology and preventive medicine in the School of Public Health and Preventive Medicine at Monash University.

The report was published online in the New England Journal of Medicine to coincide with the presentation of the study findings at the European Society of Intensive Care Medicine meeting in Vienna, Austria.

The current practice is safe

The current practice is to use the oldest available blood, Nichol said. Red blood cells can be stored for up to 42 days, the researchers noted.

“But due to concerns about the use of older blood, some blood banks had been reducing the age of the blood they transfuse,” Nichol said. Reducing the age of blood for transfusions, however, may result in more blood shortages, he pointed out.

“The current practice is safe and doctors no longer need to try and get the freshest available blood for their patients,” Nichol said. He added that using newer blood to give transfusions to critically ill patients may be harmful.

Small difference in death figures

From November 2012 through December 2016, the researchers randomly assigned nearly 5 000 critically ill patients to receive blood transfusions with either newer or older blood. The patients were from 59 medical centres in five countries – Australia, Finland, Ireland, New Zealand and Saudi Arabia.

Newer blood had been stored for an average of 11 days, while older blood was about 22 days old.

Ninety days after the transfusion, 24.8% of patients who received newer blood died, while 24.1% of those who had received older blood died, the findings showed.

After six months, the difference in deaths between those who received newer or older blood remained less than 1%.

According to Dr Edward Murphy, a professor of laboratory medicine at the University of California, San Francisco, these findings are consistent with other recent studies. “To my mind, the issue is settled that there is not a significant difference in outcomes related to how you store the blood cells,” Murphy said. “It’s reassuring that there is no difference.”

Image credit: iStock 

Share Button

Health24.com | This explains why you get clots in your period blood

Just because you’ve been getting a period every month, give or take, since puberty doesn’t mean that you have it all figured out.

For example, why on earth do you sometimes have large, dark clumps of jelly sticking to your menstrual pad or tampon? Shouldn’t menstruation blood be more of a liquid than a jam?

Well, just like blood running throughout your body can clot, so can your period blood. But while a clot in your leg can be ominous, clots in periods are completely normal and generally nothing to worry about.

Why are there clots in period blood?

Susan Wysocki, a nurse practitioner and board member of the American Sexual Health Association, explains, “Our bodies are engineered in a way that blood, with the help of internal chemicals, clots so that we don’t bleed to death.”

Typically, anti-coagulants released by the body during menstruation fend off period clots. But sometimes, especially if you have a heavy flow, not all of your uterine tissue is able to be broken down, which leads to clots forming and being released during menstruation.

These clots are typically red or dark in colour and appear during the heaviest days of a woman’s period.

Read more: How to tell the difference between period blood and spotting

Do all women get period clots?

In short, no. “It really depends on individual chemistry and whether they have a heavy or light period,” Wysocki says.

It also isn’t unusual to experience clots sporadically throughout your years of menstruation. Interestingly enough, women might notice period clots during the first and last years of their periods.

“It’s not unusual for women to have heavy, heavy bleeding during puberty”, which could likely involve clotting, Wysocki says.

On the other end of the spectrum are peri-menopausal women, whose ovulation and menstruation are beginning to occur further apart. When they finally do start bleeding, their periods might be heavier than they’re used to and contain clots.

Read more: What your period blood consistency says about your health

What does this mean for your health?

Usually period clots are nothing to worry about. But in some cases, it can be a sign of a bigger medical problem.

According to Wysocki, it’s possible a sudden change could be due to a miscarriage, disease, or infection. (Although in these cases, clotting would probably be accompanied by pain and other symptoms.)

Clot-filled periods could also be a sign of uterine fibroids, or small, non-cancerous growths in the uterus that a study out of the Women’s Hospital of Birmingham found will be experienced by 70% of women before they turn 50.

Read more: Here’s why you should always masturbate on your period

When should you see a doctor?

There are some instances when you should talk to a medical professional. For example, clotting that’s accompanied by weakness and fatigue could be a sign of anaemia, a condition in which your body doesn’t produce enough red blood cells to carry oxygen.

Wysocki also says that teens who experience heavy, clot-filled periods which leave them pale and light-headed should consult a doctor to rule out von Willebrand disease (VWD), a condition that prevents blood from clotting properly. (She says women typically discover if they have VWD during adolescence due to how annoying and disruptive the periods are.)

Wysocki also notes that women should also consult a professional if they notice a sudden change in their period or if they’re experiencing overall discomfort.

“Some people might think that ‘normal’ is being miserable, which it doesn’t have to be,” she says. Hormonal contraceptives including the pill, patch and IUD are effective ways to alleviate heavy periods – and the clots that go with them.

This article was originally published on www.womenshealthsa.co.za

Image credit: iStock

Share Button

Health24.com | Could babies’ umbilical cords help heart patients?

Instead of discarding the umbilical cord after birth, new research suggests the stem cells it contains could potentially be used to improve the lives of people with heart failure.

Stem cell research is being done on an ongoing basis to ascertain which medical conditions could benefit from stem cell therapy.

With parental permission, doctors harvested stem cells from umbilical cords that were then injected into people with heart failure.

An increase in heart function

People who received those injections were monitored for a year, and were found to have an increase in heart muscle function. Study volunteers also reported positive changes in their day-to-day lives, regaining the ability to do things such as drive a car.

“Their quality of life really improved,” said study author Dr Fernando Figueroa. He’s a professor and programme director in translational research in cell therapy at the University of the Andes School of Medicine in Chile.

People have reported among other things more energy and improved sexual function after stem cell infusions. 

Results need to be interpreted with caution

At least one expert suggested interpreting the study results with caution, however.

Dr Mary Norine Walsh, medical director of the cardiac transplantation programme at St. Vincent Heart Center in Indianapolis, said, “It’s very encouraging, but the limitations of this study are that it was done in just a few patients and they were almost all men, and they were not that ill at baseline.”

Walsh noted that because the study volunteers weren’t very ill, it’s not clear how patients would respond if they were sicker. She also pointed out that the study only had short-term data.

“But it is an interesting study because the investigators demonstrated that for those that received stem cells there was an improvement compared to the patients who received the placebo,” Walsh said.

A noninvasive procedure

The study included 30 patients, ages 18 to 75, who were receiving medication for heart failure, but were in stable condition.

The patients received one intravenous infusion of stem cells either from an umbilical cord or a placebo.

“The rationale behind our trial was to overcome two main hurdles that are facing stem cells today,” said study co-author Maroun Khoury, a professor at the University of the Andes School of Medicine.

“The first is that many stem cell treatments require surgery to inject the cells into the heart muscles. With this, it was a noninvasive procedure where the patient had an injection, was monitored for two hours and then went home,” Khoury said.

“The second is the variability. There have been a lot of clinical trials conducted where you are not able to see the outcome because they are using the cells of their donors, and the outcome will vary depending on the donor’s cells,” he explained.

The study was published on 26 September in the American Heart Association’s Circulation Research.

Heart function improved for a year

“We decided to use one source of cells from an umbilical cord donation so the product is not a variable, it’s constant, and the only variable is the patient,” Khoury said.

The study authors were surprised and encouraged by the results.

Based on previous animal research they expected the stem cells to travel to the lungs.

Patients only had one injection, done in a peripheral vein. As expected, the stem cells traveled to the lungs, yet somehow heart function improved for an entire year, according to the study. Figueroa said the results were “kind of amazing”.

No adverse side effects were found as a result of these injections.

Follow-up studies needed

The researchers plan to follow up with the study patients for three years to analyse the long-term outcome after one injection.

If the research continues to prove that umbilical cord stem cells are a viable option, Khoury said that they should be relatively easy to obtain. Most parents of newborns were happy to donate them when they learned they’d be used for a medical treatment, he said.

However, until that time, Walsh, who is also the president of the American College of Cardiology, encouraged heart patients to continue with their treatments.

“We have other therapies that can improve heart function and quality of life,” she said.

“It’s important for people to know that and take action and see their doctor if they feel ill. For many patients, our usual or standard therapy can be lifesaving,” Walsh said.

Stem cell bank in South Africa

Stem cell banks in South Africa, such as Cryo-Save, specifically bank umbilical cord blood that can used for medical purposes. According to Cryo-Save, stem cells from cord blood are “younger” than those in bone marrow and have a significantly greater capacity to multiply and grow (proliferate) and to differentiate into different types of cells.  As these stem cells are not yet exposed to outside factors, thus less likely to cause complications.

Cord blood is collected, tested, cryopreserved and used as needed. Unlike in the case of bone marrow, there is no need to take time to locate a possible donor and then determine whether they are still willing and able to donate when needed.

If you need more information, do not hesitate to visit the Cryo-Save website.

Image credit: iStock

Share Button

A Parkinson’s Drug Could Be Used To Stop Cancer Too

A drug commonly used to treat Parkinson’s disease could be repurposed as cancer medication after trials demonstrated that it has significant anti-cancer effects.

Carbidopa, a drug prescribed to patients alongside levodopa or L-DOPA (in order to reduce the med’s negative nauseating side effects) inhibits the growth of cells and tumours in mice, according to the study published in the Biochemical Journal.

Lead author on the study, Dr Yangzom Bhutia, said: “Carbidopa as an anti-cancer agent to treat [pancreatic] cancer would be something truly amazing.” 

Kilav via Getty Images

It is estimated that around 1 in every 500 people in the UK are affected by Parkinson’s disease, meaning there is approximately 127,000 people living with the condition.

The degenerative neurological disorder influences movement and motor skills, with symptoms including shaking, rigidity and difficulty in walking. But there is currently no cure, only things that can slow the progression.

One of these treatments is a combination of dopamine-producing drug L-DOPA and carbidopa, which is taken to counteract the effects of excess dopamine travelling around the body, as only 5-10% of L-DOPA is actually absorbed and crosses the blood-brain barrier.

Patients who take this magical cocktail of drugs have been shown to have lower cancer rates than most of the population (except in the case of melanoma).

L-DOPA has already been investigated in the past and was found not to be the cause of the reduced cancer stats, so Bhutia’s team decided to look at carbidopa instead: “Interestingly, no one has previously suspected carbidopa as a potential player in this phenomenon,” he said.

They then tested the effects of carbidopa on a human pancreatic cancer cell line and also in mouse models of pancreatic cancer and found it did “significantly” inhibit the growth of cancerous cells.

The recommended dose of carbidopa for Parkinson’s disease patients is 200 mg/day, but when given at a dose even as high as 450 mg/day, they found there are no side effects, so it could be prescribed in high quantities to fight cancer.

The team are hoping that moving this research into clinical trials will not be too difficult, or expensive, as the drug is already FDA-approved for Parkinson’s and therefore wouldn’t require rigorous testing that new drugs to the market normally have to undergo.

“We would like to partner with oncologists to design and conduct clinical trials in cancer patients to establish whether or not carbidopa would be useful as an anticancer drug in humans,” said Bhutia.

Parkinson’s expert, Professor Aideen Sullivan, University College, Cork, added: “Since carbidopa has already been proven to be safe and well-tolerated by people with Parkinson’s, its application in cancer treatment, where most current therapies are associated with severe and long-lasting side-effects, will be welcomed by patients.”

Share Button

‘Mentally impaired’ missing out on council tax discount

Local councils are accused of being slow to offer help and information to those eligible.

Share Button